Neggers SJ - Search Results

1

Review of current and emerging treatment options in acromegaly.

Muhammad A, van der Lely AJ, Neggers SJ. Muhammad A, et al. Among authors: neggers sj. Neth J Med. 2015 Oct;73(8):362-7. Neth J Med. 2015. PMID: 26478545 Free article. Review.

2

Long-term efficacy and safety of combined treatment of somatostatin analogs and pegvisomant in acromegaly.

Neggers SJ, van Aken MO, Janssen JA, Feelders RA, de Herder WW, van der Lely AJ. Neggers SJ, et al. J Clin Endocrinol Metab. 2007 Dec;92(12):4598-601. doi: 10.1210/jc.2007-1234. Epub 2007 Sep 25. J Clin Endocrinol Metab. 2007. PMID: 17895318

3

Cushing's syndrome due to ectopic ACTH production by (neuroendocrine) prostate carcinoma.

Alwani RA, Neggers SJ, van der Klift M, Baggen MG, van Leenders GJ, van Aken MO, van der Lely AJ, de Herder WW, Feelders RA. Alwani RA, et al. Among authors: neggers sj. Pituitary. 2009;12(3):280-3. doi: 10.1007/s11102-008-0100-z. Pituitary. 2009. PMID: 18322802

4

Quality of life in acromegalic patients during long-term somatostatin analog treatment with and without pegvisomant.

Neggers SJ, van Aken MO, de Herder WW, Feelders RA, Janssen JA, Badia X, Webb SM, van der Lely AJ. Neggers SJ, et al. J Clin Endocrinol Metab. 2008 Oct;93(10):3853-9. doi: 10.1210/jc.2008-0669. Epub 2008 Jul 22. J Clin Endocrinol Metab. 2008. PMID: 18647806 Clinical Trial.

5

Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients.

Neggers SJ, de Herder WW, Janssen JA, Feelders RA, van der Lely AJ. Neggers SJ, et al. Eur J Endocrinol. 2009 Apr;160(4):529-33. doi: 10.1530/EJE-08-0843. Epub 2009 Jan 13. Eur J Endocrinol. 2009. PMID: 19141604

6

Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.

van der Lely AJ, Bernabeu I, Cap J, Caron P, Colao A, Marek J, Neggers S, Birman P. van der Lely AJ, et al. Eur J Endocrinol. 2011 Mar;164(3):325-33. doi: 10.1530/EJE-10-0867. Epub 2010 Dec 10. Eur J Endocrinol. 2011. PMID: 21148630 Clinical Trial.

7

Modulation of glucocorticoid metabolism by the GH-IGF-I axis.

Neggers SJCMM, van der Lely AJ. Neggers SJCMM, et al. Endocr Dev. 2011;20:181-186. doi: 10.1159/000321243. Epub 2010 Dec 16. Endocr Dev. 2011. PMID: 21164271 Review.

8

Conversion of daily pegvisomant to weekly pegvisomant combined with long-acting somatostatin analogs, in controlled acromegaly patients.

Neggers SJ, de Herder WW, Feelders RA, van der Lely AJ. Neggers SJ, et al. Pituitary. 2011 Sep;14(3):253-8. doi: 10.1007/s11102-010-0289-5. Pituitary. 2011. PMID: 21221818 Free PMC article.

9

Combination treatment with somatostatin analogues and pegvisomant in acromegaly.

Neggers SJ, van der Lely AJ. Neggers SJ, et al. Growth Horm IGF Res. 2011 Jun;21(3):129-33. doi: 10.1016/j.ghir.2011.03.004. Epub 2011 Apr 16. Growth Horm IGF Res. 2011. PMID: 21498099 Free article. Review.

10

What is active acromegaly and which parameters do we have?

Neggers SJ, Biermasz NR, van der Lely AJ. Neggers SJ, et al. Clin Endocrinol (Oxf). 2012 May;76(5):609-14. doi: 10.1111/j.1365-2265.2012.04346.x. Clin Endocrinol (Oxf). 2012. PMID: 22268623 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters